Dow Up0.11% Nasdaq Up0.50%

Sunesis Pharmaceuticals, Inc. (SNSS)

-NasdaqCM
7.49 Down 0.29(3.73%) Aug 29, 4:00PM EDT
|After Hours : 7.56 Up 0.07 (0.93%) Aug 29, 5:32PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue 1,989   1,995   1,989   1,989  
Cost of Revenue -   -   -   -  
Gross Profit 1,989   1,995   1,989   1,989  
Operating Expenses
Research Development7,206  7,552  6,883  6,957  
Selling General and Administrative6,387  3,417  2,698  2,807  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (11,604) (8,974) (7,592) (7,775)
Income from Continuing Operations
Total Other Income/Expenses Net293  (5,052)1,038  863  
Earnings Before Interest And Taxes(11,311)(14,026)(6,554)(6,912)
Interest Expense470  547  623  695  
Income Before Tax(11,781)(14,573)(7,177)(7,607)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(11,781)(14,573)(7,177)(7,607)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (11,781) (14,573) (7,177) (7,607)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (11,781) (14,573) (7,177) (7,607)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.